Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tobias Pischon"'
Autor:
Cornelia Weikert, Anna Floegel, Jerzy Adamski, Cornelia Prehn, Stefan Dietrich, H. Boeing, Dagmar Drogan, Tobias Pischon
Publikováno v:
Hypertension. 68:471-477
Metabolomics is a promising tool to gain new insights into early metabolic alterations preceding the development of hypertension in humans. We therefore aimed to identify metabolites associated with incident hypertension using measured data of serum
Autor:
Hans-Ulrich Häring, Cornelia Weikert, Matthias B. Schulze, Hans-Georg Joost, Tobias Pischon, Klaus Berger, Norbert Stefan, Heiner Boeing, Andreas Fritsche
Publikováno v:
Circulation. 118:2555-2562
Background— Fetuin-A, a protein almost exclusively secreted by the liver, induces insulin resistance and subclinical inflammation in rodents. Circulating fetuin-A levels are elevated in humans with metabolic syndrome and insulin resistance, conditi
Autor:
Tobias Pischon, JoAnn E. Manson, Kenneth J. Mukamal, Morten Grønbæk, Eric B. Rimm, Meir J. Stampfer, Majken K. Jensen
Publikováno v:
Circulation. 112:1406-1413
Background— The associations of drinking frequency and quantity with risk of myocardial infarction have not been studied among women, and the degree to which specific risk factors mediate the inverse association of drinking frequency with risk of m
Publikováno v:
Hypertension. 37:250-254
One of the arguments put forward against the primary use of β-blockers has been concern about adverse metabolic effects, such as unfavorable effects on lipids or insulin sensitivity. Another less-appreciated potential drawback is their propensity to
Publikováno v:
Circulation. 115
To the Editor: We read with interest the report by Sattar and colleagues1 that shows no significant relationship of plasma adiponectin levels with risk of coronary heart disease in the British Regional Heart Study. In a summary of published studies,